Skip to main content

Ferring Pharmaceuticals and PharmaBiome announced a research & development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology.

The deal provides Ferring with exclusive rights to develop, manufacture and commercialise next generation microbiome-based therapeutics within the field of gastroenterology arising out of the collaboration. The financial details of this deal are undisclosed.

Read more in the official press release. 

Share this article

View all news

Sign up to receive our newsletter in your inbox.